ID: ALA5220651

Max Phase: Preclinical

Molecular Formula: C25H48IN3O2

Molecular Weight: 422.68

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCC(C)Nc1c(NCC[N+](C)(C)C)c(=O)c1=O.[I-]

Standard InChI:  InChI=1S/C25H47N3O2.HI/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-21(2)27-23-22(24(29)25(23)30)26-19-20-28(3,4)5;/h21H,6-20H2,1-5H3,(H-,26,27,29,30);1H

Standard InChI Key:  ASXZFLMDZIOWGA-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania infantum 5912 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 422.68Molecular Weight (Monoisotopic): 422.3741AlogP: 5.29#Rotatable Bonds: 19
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 1.84CX LogD: 1.84
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.18Np Likeness Score: 0.15

References

1. Chasák J, Šlachtová V, Urban M, Brulíková L..  (2021)  Squaric acid analogues in medicinal chemistry.,  209  [PMID:33035923] [10.1016/j.ejmech.2020.112872]

Source